GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+38.9%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$607M
AUM Growth
+$607M
(-45%)
Cap. Flow
-$711M
Cap. Flow
% of AUM
-117.17%
Top 10 Holdings %
Top 10 Hldgs %
58.82%
Holding
46
New
12
Increased
3
Reduced
16
Closed
14
Top Buys
| 1 |
Rocket Pharmaceuticals
RCKT
|
$38.4M |
| 2 |
Ocular Therapeutix
OCUL
|
$17.7M |
| 3 |
Insulet
PODD
|
$15.3M |
| 4 |
Theravance Biopharma
TBPH
|
$14.7M |
| 5 |
Arvinas
ARVN
|
$13.9M |
Top Sells
| 1 |
Iovance Biotherapeutics
IOVA
|
$137M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$131M |
| 3 |
United Therapeutics
UTHR
|
$74.5M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$64.2M |
| 5 |
Cytokinetics
CYTK
|
$55.2M |
Sector Composition
| 1 | Healthcare | 93.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Geron
GERN
$893M
| $8.04M | 1.31% |
5,055,189
-4,630,339
| -48% | -$7.36M |
|
27
Pulmonx
LUNG
$67.6M
| $4.44M | 0.72% |
+64,345
| New | +$4.44M |
|
28
Ionis Pharmaceuticals
IONS
$9.64B
| $4.24M | 0.69% |
+75,000
| New | +$4.24M |
|
29
ARS Pharmaceuticals
SPRY
$1.08B
| $3.24M | 0.53% |
+70,000
| New | +$3.24M |
|
30
Aurinia Pharmaceuticals
AUPH
$1.58B
| $2.42M | 0.39% |
175,000
-2,310,327
| -93% | -$31.9M |
|
31
Tempest Therapeutics
TPST
$46.6M
| $578K | 0.09% |
270,000
-907,900
| -77% | -$1.94M |
|
|
BHVN
32
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-435,000
| Closed | -$28.3M |
|
|
TBIO
33
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| – | – |
-943,339
| Closed | -$12.8M |
|
|
CCXI
34
DELISTED
ChemoCentryx, Inc.
CCXI
| – | – |
-253,230
| Closed | -$13.9M |
|
|
OYST
35
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| – | – |
-70,121
| Closed | -$1.48M |
|
|
VRAY
36
DELISTED
ViewRay, Inc.
VRAY
| – | – |
-2,655,763
| Closed | -$9.3M |
|
37
TG Therapeutics
TGTX
$5.03B
| – | – |
-1,600,000
| Closed | -$42.8M |
|
38
Sangamo Therapeutics
SGMO
$161M
| – | – |
-1,589,724
| Closed | -$15M |
|
39
Liquidia Corp
LQDA
$2.52B
| – | – |
-1,189,607
| Closed | -$5.85M |
|
40
Lantheus
LNTH
$3.75B
| – | – |
-594,750
| Closed | -$7.54M |
|
|
IVA
41
Inventiva
IVA
$802M
| – | – |
-999,422
| Closed | -$11.8M |
|
42
Glaukos
GKOS
$5.42B
| – | – |
-446,097
| Closed | -$22.1M |
|
43
FibroGen
FGEN
$48.4M
| – | – |
0
| – | – |
|
|
44
Cytokinetics
CYTK
$5.98B
| – | – |
-2,549,525
| Closed | -$55.2M |
|
45
Allogene Therapeutics
ALLO
$249M
| – | – |
-328,817
| Closed | -$12.4M |
|
46
Abeona Therapeutics
ABEO
$356M
| – | – |
-3,892,921
| Closed | -$3.97M |
|